FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2326972643> ?p ?o ?g. }

• W2326972643 abstract "Breast cancer is the second most frequently diagnosed cancer in U. S. women with >200,000 new cases estimated for 2010. Resistance to standard chemotherapy remains a significant clinical challenge. Thus, the identification of novel molecular biomarkers that predict response to treatment may improve therapeutic decision making and outcomes. Recently it has been reported that the level and activity of the dsRNA-dependent protein kinase, PKR, is increased in mammary carcinoma cell lines and more aggressive primary tumor specimens. Previously, our laboratory has determined that PKR is a key regulator of cell proliferation, apoptosis and transformation. PKR is activated by diverse cellular stresses including growth factor withdrawal from hematopoietic cells, inflammatory cytokine treatment or viral infection to initiate apoptosis presumably as a result eIF2α phosphorylation and inhibition of protein synthesis. However, activated PKR may also promote apoptosis by inhibiting Bcl2 phosphorylation and regulate cell proliferation by mechanisms dependent on p53, STAT1 or NF-κB. In order to gain insight into how PKR signaling may affect breast cancer development and sensitivity to chemotherapy, we measured the level of PKR in primary breast cancer (and paired, normal adjacent tissue) by immunohistochemical staining of a breast tumor tissue microarray containing 50 cases. Increased PKR staining was observed in all tumor types tested (infiltrating ductal carcinoma, mucinous adenocarcinoma, medullary carcinoma, Paget9s disease, carcinosarcoma, cystosarcoma phyllodes and benign fibroadenoma) compared to normal adjacent tissue. Furthermore, elevated PKR expression directly correlates with increased tumor grade indicating a more aggressive phenotype. To determine whether PKR may be required for tumor response to doxorubicin, we employed a siRNA strategy to knock-down PKR by >75% in several breast cell lines. Interestingly, basal PKR activity is dramatically higher in those cell lines derived from human mammary carcinoma (i.e. MCF7 and T-47D) compared to a “nontransformed” mammary epithelial cell line (MCF10A). Furthermore, timecourse and dose response studies with doxorubicin, a frequently used and effective chemotherapy, revealed that cells with reduced PKR are significantly less sensitive to the drug compared to control siRNA cells with higher PKR. Interestingly, phosphorylation of eIF2α is unaffected by reduced PKR expression in MCF7 cells even with the highest dose of doxorubicin. This indicates that the mechanism by which PKR promotes doxorubicin sensitivity may be independent of eIF2α phosphorylation and protein synthesis inhibition. Together, these results suggest that increased PKR expression may be a useful biomarker for more aggressive breast tumors and for predicting response to doxorubicin treatment. Based on this model, aggressive tumors that do not display elevated PKR are predicted to be resistant to doxorubicin. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 203. doi:10.1158/1538-7445.AM2011-203" @default.
• W2326972643 created "2016-06-24" @default.
• W2326972643 creator A5008754012 @default.
• W2326972643 creator A5030768537 @default.
• W2326972643 creator A5031853527 @default.
• W2326972643 creator A5074398041 @default.
• W2326972643 date "2011-04-15" @default.
• W2326972643 modified "2023-09-27" @default.
• W2326972643 title "Abstract 203: PKR is a doxorubicin sensitivity biomarker for breast cancer" @default.
• W2326972643 doi "https://doi.org/10.1158/1538-7445.am2011-203" @default.
• W2326972643 hasPublicationYear "2011" @default.
• W2326972643 type Work @default.
• W2326972643 sameAs 2326972643 @default.
• W2326972643 citedByCount "0" @default.
• W2326972643 crossrefType "proceedings-article" @default.
• W2326972643 hasAuthorship W2326972643A5008754012 @default.
• W2326972643 hasAuthorship W2326972643A5030768537 @default.
• W2326972643 hasAuthorship W2326972643A5031853527 @default.
• W2326972643 hasAuthorship W2326972643A5074398041 @default.
• W2326972643 hasConcept C121608353 @default.
• W2326972643 hasConcept C126322002 @default.
• W2326972643 hasConcept C142724271 @default.
• W2326972643 hasConcept C143998085 @default.
• W2326972643 hasConcept C161238802 @default.
• W2326972643 hasConcept C2776694085 @default.
• W2326972643 hasConcept C2781303535 @default.
• W2326972643 hasConcept C29537977 @default.
• W2326972643 hasConcept C3018521938 @default.
• W2326972643 hasConcept C502942594 @default.
• W2326972643 hasConcept C530470458 @default.
• W2326972643 hasConcept C555283112 @default.
• W2326972643 hasConcept C71924100 @default.
• W2326972643 hasConcept C82495950 @default.
• W2326972643 hasConcept C86803240 @default.
• W2326972643 hasConceptScore W2326972643C121608353 @default.
• W2326972643 hasConceptScore W2326972643C126322002 @default.
• W2326972643 hasConceptScore W2326972643C142724271 @default.
• W2326972643 hasConceptScore W2326972643C143998085 @default.
• W2326972643 hasConceptScore W2326972643C161238802 @default.
• W2326972643 hasConceptScore W2326972643C2776694085 @default.
• W2326972643 hasConceptScore W2326972643C2781303535 @default.
• W2326972643 hasConceptScore W2326972643C29537977 @default.
• W2326972643 hasConceptScore W2326972643C3018521938 @default.
• W2326972643 hasConceptScore W2326972643C502942594 @default.
• W2326972643 hasConceptScore W2326972643C530470458 @default.
• W2326972643 hasConceptScore W2326972643C555283112 @default.
• W2326972643 hasConceptScore W2326972643C71924100 @default.
• W2326972643 hasConceptScore W2326972643C82495950 @default.
• W2326972643 hasConceptScore W2326972643C86803240 @default.
• W2326972643 hasLocation W23269726431 @default.
• W2326972643 hasOpenAccess W2326972643 @default.
• W2326972643 hasPrimaryLocation W23269726431 @default.
• W2326972643 hasRelatedWork W1079999522 @default.
• W2326972643 hasRelatedWork W1458591326 @default.
• W2326972643 hasRelatedWork W1508313146 @default.
• W2326972643 hasRelatedWork W1596923719 @default.
• W2326972643 hasRelatedWork W2001138013 @default.
• W2326972643 hasRelatedWork W2027423872 @default.
• W2326972643 hasRelatedWork W2037578345 @default.
• W2326972643 hasRelatedWork W2038740066 @default.
• W2326972643 hasRelatedWork W2066687597 @default.
• W2326972643 hasRelatedWork W2086266172 @default.
• W2326972643 hasRelatedWork W2088379844 @default.
• W2326972643 hasRelatedWork W2132207113 @default.
• W2326972643 hasRelatedWork W2160043536 @default.
• W2326972643 hasRelatedWork W2171849434 @default.
• W2326972643 hasRelatedWork W2312543879 @default.
• W2326972643 hasRelatedWork W2322464729 @default.
• W2326972643 hasRelatedWork W2328345356 @default.
• W2326972643 hasRelatedWork W2386778271 @default.
• W2326972643 hasRelatedWork W2461562722 @default.
• W2326972643 hasRelatedWork W2766191408 @default.
• W2326972643 isParatext "false" @default.
• W2326972643 isRetracted "false" @default.
• W2326972643 magId "2326972643" @default.
• W2326972643 workType "article" @default.